Archon Biosciences logo

Archon Biosciences

Archon Biosciences is a seed-stage biotech company based in Seattle, Washington, developing AI-designed protein structures called...

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Type
Corporation Seattle business license
Employees
26
Registered name
Archon Biosciences Inc Seattle business license
Stage
Seed

University of Washington CoMotion Spinoffs Launch AI, Biotech, and Mobility Innovations in Early 2025

In the first half of 2025, multiple University of Washington spinoff companies supported by CoMotion licensed UW technology to enter markets with innovations in biotech, AI education tools, and smart parking solutions. These startups benefited from CoMotion’s development programs and grants to advance their technologies from lab research to commercial applications.

Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model

Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.

People

Online